Molecular basis for polycythemia

Current Opinion in Hematology

Volumn 6, Issue 2, 1999, Pages 100-109

  Prchal, Jaroslav F ^a,b   Prchal, Josef T ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; HEMOGLOBIN;

ERYTHROPOIESIS; HEMATOCRIT; HUMAN; METHEMOGLOBINEMIA; MOLECULAR BIOLOGY; POLYCYTHEMIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOSENSING TECHNIQUES; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OXYGEN; POLYCYTHEMIA; RECEPTORS, ANGIOTENSIN; RECEPTORS, ERYTHROPOIETIN;

EID: 0032800467     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199903000-00008     Document Type: Review

References (96)

1. Adamson J: Familial polycythemia. Semin Hematol 1975, 12:383-391.
2. Prchal J: Primary polycythemias. Curr Opin Hematol 1995, 2:146-152.
3. Kralovics R, Sokol L, Tze L, Guan Y, Prchal JF, Prchal JT: Absence of polycythemia phenotype in a child in PFCP family with EPO receptor mutation. Blood 1995, 66:18a.
4. Bunn H, Poyton R: Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996, 76:839-885.
5. Lemarchandel V, Joulin V, Valentin C, Ross R, Galacteros F, Rosa J, Cohen-Solal M: Compound heterozygosity in a complete erythrocyte biphosphoglycerate mutase deficiency. Blood 1992, 80:2643-2649.
6. Eaves C, Eaves A: Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood 1978, 52:1196-1210.
7. Stopka T, Zivny J, Stopkova P, Prchal J, Prchal J: Human hematopoietic progenitors express erythropoietin. Blood 1998, 91:3766-3772. Erythropoietin is normally produced by kidney cells.
8. Krantz S: Erythropoietin. Blood 1991, 77:419-434.
9. Sawyer S, Krantz S, Goldwasser E: Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J Biol Chem 1987, 262:5554-5562.
10. Spivak J: The mechanism of action of erythropoietin. Int J Cell Cloning 1986, 4:139-166.
11. Semenza G, Wang G: A nuclear factor induced by gypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454.
12. Kvietika I, Wenger R, Marti H, Gassmann M: The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res 1995, 23:4542-4550.
13. Wiener C, Booth G, Semenza G: In vivo expression of MRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 1996, 225:485-488.
14. Semenza G, Roth P, Fang H, Wang G: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor. J Biol Chem 1994, 269:23757-23763.
15. Wang G, Semenza G: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995, 270:1230-1237.
16. Wang G, Semenza G: Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 1993, 268:21513-21518.
17. Wang G, Jiang B, Semenza G: Effect of protein kinase and phosphatase inhibitors on expression of hyoxia-inducible factor 1. J Biochem Biophys Res Commun 1995, 216:669-675.
18. 2 tension. Am J Physiol 1996, 271:1172-1180.
19. Jones S, D'Andrea A, Haones L, Wong G: Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood 1990, 76:31-35.
20. Koury M, Bondurant M: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990, 248:378-381.
21. D'Andrea A, Lodish H, Wong G: Expression cloning of the murine erythropoietin receptor. Cell 1989, 57:277-285.
22. D'Andrea A, Yoshimura A, Youssoufian H, Zon L, Koo J-W, Lodish H: The cytoplasmic region of the erythropoietin receptor contains non-overlapping positive and negative growth-regulatory domains. Mol Cell Biol 1991, 11:1980-1987.
23. Witthuhn B, Quelle F, Silvennoinen O, Ui T, Tang B, Miura O, Ihle J: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993, 74:227-238.
24. Klingmuller U, Lorenz U, Cantley L, Neel B, Lodish H: Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995, 80:729-738.
25. Xiao S, Rose D, Sasaoka T, Maegawa H, Burke T, Roller P, et al.: Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitotic signal transduction. J Biol Chem 1994, 269:21244-21248.
26. Maouche L, Toumamille C, Hattab C, Boffa G, Cartron J, Chretien S: Cloning of the gene encoding the human erythropoietin receptor. Blood 1991, 787:2557-2563.
27. Noguchi C, Bae K, Chin K, Wada Y, Schechter A, Hankins W: Cloning of the human erythropoietin receptor gene. Blood 1991, 78:2548-2556.
28. Penny L, Forget B: Genomic organization of the human erythropoietin receptor gene. Genomics 1991, 11:974-980.
29. Winkelmann J, Penny L, Deaven L, Forget B, Jenkins R: The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19q. Blood 1990, 76:24.
30. Kralovics R, Sokol L, Broxson E, Prchal J: The erythropoietin receptor gene is not linked with polycythemia phenotype in a family with autosomal dominant primary polycythemia. Proc Assoc Am Physicians 1997, 109:580-585.
31. Gregg XT, Liu Y, Prchal JT: Development of a new clonality assay based on transcriptional polymorphisms Iduronate-2-Sulfate gene. Presented at ASH 38th Annual Meeting. Blood 1996, 88(suppl):1469a.
32. Correa P, Axelrad A: Production of erythropoietin bursts by progenitor cells from human peripheral blood in an improved serum-free medium: role of insulin-like growth factor I. Blood 1992, 78:2823-2833.
33. Correa P, Eskinazi D, Axelrad A: Circulating erythroid progenitors in polycythemia vera are hypersensitive to insultin-like growth factor 1 in vitro: studies in an improved serum-free medium. Blood 1994, 83:99-112.
34. Konwalinka G, Geissler D, Peschle C, Breier C, Grunewald K, Odavic R, Braunsteiner H: Human erythropoiesis in vitro and the source of burst-promoting activity in a serum-free system. Exp Hematol 1986, 14:899-903.
35. Stewart S, Zhu B, Axelrad A: A "serum-free" medium for the production of erythropoietic bursts by murine bone marrow cells. Exp Hematol 1984, 12:309-318.
36. Kurtz A, Matter R, Eckhardt K-U, Zapf J: Erythropoiesis, serum erythropoietin, and IGF-I in rats during accelerated growth. Acta Endocrinol 1990, 122:323-326.
37. McLellan K, Stuart B, Bocking A, Delhanty P, Phillips I, Hill D, Han V: Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus. Endocrinology 1992, 131:1619-1628.
38. Gomez A, Norwood V: Developmental consequences of the reninangiotensin system. Am J Kidney Dis 1995, 26:409-431.
39. Gomez A: Angiotensin receptors: relevance in development and disease states. Exp Nephrol 1994, 2:259-268.
40. Ray P, Aguilera G, Kopp J, Horikoshi S, Klotman P: Angiotensin li receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney Int 1991, 40:764-771.
41. Tufro-Meddia A, Gomer R: Ontogeny of the renin-angiotensis system. Semin Nephrol 1993, 13:519-530.
42. Perazella M, McPhedran P, Kliger A, Lorber M, Levy E, Bia M: Enalapril treatment of post-transplant erythrocytosis: efficacy independent of circulating erythropoietin levels. Am J Kidney Dis 1995, 26:495-500.
43. Azizi M, Rousseau A, Ezan E, Guyene T, Michelet S, Grognet J, et al.: Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 1996, 97:839-844.
44. Pratt MC, Lewis-Barned NJ, Walker RJ, Bailey RR, Shand BI, Livesey J: Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmac 1974, 34:363-365.
45. Sizeland P, Bailey R, Lynn K, Robson R: Anemia and angiotensin-converting enzyme inhibition in renal transplant recipients. J Cardiovasc Pharmacol 1990, 16(suppl):S117-S119.
46. Julian B, Barker C, Emanuel P, Prchal J: Mechanisms of erythropoiesis differ between post-transplant erythrocytosis and polycthemia vera or familial polycythemia. J Am Soc Nephrol 1994, 5:1016-1019.
47. Brantley R, Mrug M, Barker C, Gaston R, Prchal J, Julian BA: Blockade of angiotensis II AI1 receptor in post-transplant erythrocytosis. AM J Nephrol 1996, 7:1930.
48. Polyakova L: Familial erythrocytosis among inhabitants of the Chuvash ASSR. Probl Gematol 1974, 10:30.
49. Marrero M, Schieffer B, Paxton W, Heerdt L, Berk B, Delafontaine P, Bernstein K: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995, 273:247-250.
50. Emanuel P, Eaves C, Broudy V, Papayannopoulou T, Moore M, D'Andrea A, et al.: Familial and congenital polycythemia in three unrelated families. Blood 1992, 79:3019-3030.
51. Juvonen E, Ikkala E, Fyhrquist F, Ruutu T: Autosomal dominant erythrocytosis causes by increased sensitivity to erythropoietin. Blood 1991, 78:3066-3069.
52. Prchal J, Crist W, Goldwasser E, Perrine G, Prchal J: Autosomal dominant polycythemia. Blood 1985, 66:1208-1214.
53. De La Chapelle ASP, Lehvaslaiho H, Ikkala E, Juvonen E: Familiar erythrocytosis genetically linked to erythropoietin receptor gene J. Lancet 1993, 341:82-84.
54. Sokol L, Prchal J: Two microsatellite repeat polymorphisms in the 5′ untranslated region of the erythropoietin receptor gene. Hum Mol Genetics 3 1994, 3:219.
55. Sokol L, Kralovics R, Prchal J: Proliferation of erythroid cells in PFCP associated with mutations of erythropoietin receptor (EPOR) are due to increased mitogenesis but not from inhibition of apoptosis. Blood 1995, 86:66a.
56. Damen J, Krosel J, Humophries K, Krystal G: The hyperresponsiveness of cells expressing truncated EPOR in contigent upon insulin-like growth factor in fetal calf serum. Blood 1998, 92:425-433.
57. Prchal J, Semenza G, Prchal J, Sokol L: Familial polycythemia. Science 1995, 268:1831-1832.
58. Kralovics R, Indrak K, Stopka T, Berman B, Prchal JF, Prchal JT: Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 1997, 90:2057-2061. While truncation of EPOR is often associated with polycythemia phenotype, the majority of cases of PFCP have another, yet unknown etiology.
59. Lichtman M, Murphy M, Adamson J: Detection of mutant hemoglobins with altered affinity for oxygen: a simplified technique. Ann Intern Med 1976, 84:517-520.
60. Rosa R, Prehu M-O, Beuzard Y, Rosa J: The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes. J Clin Invest 1978, 62:907-915.
61. Barichard F, Joulin V, Henry I, Garee M, Valentin C, Rosa R, et al.: Chromosomal assignment of the human 2,3-bisphosphoglycerate mutase gene (BPGM) to region 7q34→7q22. J Biol Chem 1987, 77:283-285.
62. Galacteros F, Rosa R, Prehu M, Najean Y, Calvin M: Deficit en diphosphoglycerate mutase: nouveaux cas associes a une polyglobulie [abstract]. Nouv Rev Fr Hematol 1982, 26:69.
63. Gazenko L: Pathogenetic features of hereditary erythrocytosis [PhD thesis]. Moscow: Hematological Scientific Center; 1992.
64. Polyakova L: Familial-Hereditary Erythrocytosis [PhD thesis]. Moscow: Scientific Research Institute of Hematology and Blood Transfusion; 1977.
65. Sergeyeva A, Gordeuk V, Tokarev Y, Prchal J, Sokol L, Prchal J: Congenital polycythemia in Chuvashia. Blood 1993, 89:2148-2154.
66. Adamson J, Fialkow P, Murphy S, Prchal J, Steinman L: Polycythemia vera stem cell and probable clonal origin of the disease. N Engl J Med 1976, 295:913-916.
67. Liu Y, Phelan JT, Go RCP, Prchal JF, Prchal JT: Rapid determiniation of clonality by detection of two closely-linked x-chromosome exonic polymorphisms using allele-specific PCR. J Clin Invest 1997, 99:573-587.
68. Gregg XT, Liu Y, Prchal JT, Gartland GT, Cooper MD, Prchal JF: Clonality in myeloproliferative disorders. Presented at ASH 38th Annual Meeting. Blood 1996, 88:1905a.
69. Prchal J, Axelrad A: Bone-marrow responses in polycythemia vera. N Eng J Med 1974, 289:132.
70. Weinberg R: In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders. Semin Hem 1997, 34:64-69. This is an overview of the subject of in vitro erythropoiesis in polycythemia vera and other MPDs.
71. Westwood N, Pearson T: Diagnostic application of haemopoietic progenitor culture techniques in polycythemia and thrombocythaemias. Leukemia Lymphoma 1996, 22:95-103.
72. Casadevall N, Vainchenker W, Laconbe C, Vinci G, Chapman J, Breton-Gorius J, Varet B: Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. Blood 1982, 59:447-451.
73. Shih L-Y, Lee C-T: Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood 1994, 83:744-748.
74. Zanjani E, Lutton J, Hoffman R: Erythroid colony formation by polycythemia vera one marrow in vitro: dependence on erythropoietin. J Clin Invest 1978, 59:841-848.
75. Gregg X, Prchal J: Erythropoietin receptor mutations and human disease. Semin Hematol 1997, 34:1-8. This is a comprehensive review of erythropoietin receptor mutations with additional references.
76. Perrine G, Prchal J, Prchal J: Study of a polycythemic family. Blood 1977, 50:134-138.
77. Fisher M, Prchal J, Prchal J, D'Andrea A: Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia. Blood 1994, 84:1982-1991.
78. Dai C, Krantz S, Dessypris E, Means R, Horn S, Gilbert H: Polycythemia vera II, hypersensitivity of bone marroy erythroid, granulocyte-macrophage, and megakaryocytes progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 1992, 80:891-899.
79. Dai C, Krantz S, Means R, Horn S, Gilbert H: Polycythemia vera blood burstforming units: erythroid are hypersensitive to interleukin-3. J Clin Invest 1991, 87:391-396.
80. Le Couedic J, Mitjavila M, Villeval J, Feger F, Gobert S, Mayeux P, et al.: Missense mutation of the erythropoietin receptor is a rare event in human erthroid malignancies [abstract]. Blood 1996, 87:1502.
81. Mirza A: Cellular and molecular mechanisms of IBF-1 hypersensitivity in PV [PhD thesis]. Toronto: University of Toronto; 1997.
82. Prchal J, Prchal J, Kralovics R, Eskinazi D, Axelrad A: Sensitivities of erythroid progenitor cells to erythropoietin (EPO) and insulin-like growth factor-1 (IGF-1) in patients with primary familial and congenital polycythemia (PFCP): Studies in strictly serum-free conditions. Exp Hem 1998, 26:239.
83. Dai C, Krantz S, Sawyer S: Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphate activity in polycythemia vera. Blood 1997, 89:3574-3581.
84. Kawada E, Tamura J, Kubota K, Murakami H, Naruse T, Tsuchiya J: Possible involvement of protein kinase C in the aberrant regulation of erythropoiesis in polycythemia vera. Leuk Res 1997, 21:101-105.
85. Sui X, Krantz S, Zhao Z: Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells. Blood 1997, 90:651-657.
86. Rapoport S, Leubering J: The formation of 2,3-diphosphoglycerate in rabbit erythrocytes: The existence of diphosphoglycerate mutase. J Biol Chem 1950, 183:507.
87. Andersson P, Le Blanc K, Eriksson B-A, Samuelsson J: No evidence for an altered MRNA expression or protein level or haemotopoietic cell phosphate in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythemia vera. European J Haematol 1997,59:310-317.
88. Asimakopoulos F, Hinshelwood S, Gilbert J, Delibrias C, Gottgens B, Fearon D, Green A: The gene encoding hematopoietic cell phophatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera. Oncogene 1997, 14:1215-1222.
89. Streuli M: Protein tyrosine phosphates in signaling. Curr Opin Cell Biol 1996, 8:182-188.
90. Ushikubi F, Ishibashi T, Narumiya S, Okuma M: Analysis of the defective signal transduction mechanism through the platelet thromboxane A2 receptor in a patient with polycythemia vera. Thrombos Haemost 1992, 67:144-146.
91. Horikawa Y, Matsuma I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, et al.: Markedly reduced expression of platelet c-mp1 receptor in essential thrombocythemia. Blood 1997, 90:4031-4038.
92. Moliterno A, Hankins W, Sivak J: Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 1998, 338:572-580.
93. Silva M, Richard C, Benito A, Sanz C, Olalla I, Fernandez-Luna J: Expression of Bclx in erythroid precursors from patients with polycythemia vera. N Engl J Med 1998, 338:564-571. This presents a novel potential area of research into the pathogenesis of polycythemia.
94. Le Blanc K, Berg A, Palmblad J, Samuelsson J: Stimulus-specific defect in platelet aggregation in polycythemia vera. Eur J Haematol 1994, 53:145-149.
95. Samuelsson J, Forslid J, Hed J, Palmblad J: Studies of neutorphil and monocyte oxidative responses in polycythemia vera and related myeloproliferative disorders. Br J Haematol 1994, 87:464-470.
96. Katoh O, Kimura A, Itoh T, Kuramoto A: Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders. Am J Hematol 1990, 35:145-150.